Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes

Bibliography

• Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med 2006;12(1):75-80
   PubMed Web of Science ®Google Scholar
• Flamment M, Hajduch E, Ferre P, et al. New insights into ER stress-induced insulin resistance. Trends Endocrinol Metab 2012;23(8):381-90
   PubMed Web of Science ®Google Scholar
• Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 2012;148(5):852-71
   PubMed Web of Science ®Google Scholar
• Carey DG, Jenkins AB, Campbell LV, et al. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996;45(5):633-8
   PubMed Web of Science ®Google Scholar
• Paolisso G, Gambardella A, Amato L, et al. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 1995;38(11):1295-9
   Google Scholar
• Randle PJ, Garland PB, Hales CN, et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1(7285):785-9
   PubMed Web of Science ®Google Scholar
• Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97(12):2859-65
   PubMed Web of Science ®Google Scholar
• Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008;29(3):351-66
   PubMed Web of Science ®Google Scholar
• Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002;32(Suppl 3):14-23
   PubMed Web of Science ®Google Scholar
• Cowart LA. Sphingolipids: players in the pathology of metabolic disease. Trends Endocrinol Metab 2009;20(1):34-42
   Google Scholar
• Ussher JR, Koves TR, Cadete VJ, et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 2010;59(10):2453-64
   PubMed Web of Science ®Google Scholar
• Mullen TD, Hannun YA, Obeid LM. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem J 2012;441(3):789-802
   PubMedGoogle Scholar
• Hanada K, Kumagai K, Yasuda S, et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature 2003;426(6968):803-9
   PubMed Web of Science ®Google Scholar
• Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008;9(2):139-50
   PubMed Web of Science ®Google Scholar
• Adams JMII, Pratipanawatr T, Berria R, et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004;53(1):25-31
   Google Scholar
• Coen PM, Dube JJ, Amati F, et al. Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 2010;59(1):80-8
   PubMed Web of Science ®Google Scholar
• Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 2008;29(4):381-402
   PubMed Web of Science ®Google Scholar
• Hage Hassan R, Bourron O, Hajduch E. Defect of insulin signal in peripheral tissues: important role of ceramide. World J Diabetes 2014;5(3):244-57
   PubMedGoogle Scholar
• Mahfouz R, Khoury R, Blachnio-Zabielska A, et al. Characterising the inhibitory actions of ceramide upon insulin signaling in different skeletal muscle cell models: a mechanistic insight. PLoS One 2014;9(7):e101865
   PubMed Web of Science ®Google Scholar
• Chavez JA, Summers SA. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 2003;419(2):101-9
   Google Scholar
• Hajduch E, Balendran A, Batty IH, et al. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 2001;44(2):173-83
   Google Scholar
• Nordby P, Prats C, Kristensen D, et al. Muscle ceramide content in man is higher in type I than type II fibers and not influenced by glycogen content. Eur J Appl Physiol 2010;109(5):935-43
   Google Scholar
• Asmann YW, Stump CS, Short KR, et al. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 2006;55(12):3309-19
   Google Scholar
• Cazzolli R, Carpenter L, Biden TJ, et al. A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes 2001;50(10):2210-18
   Google Scholar
• Turban S, Hajduch E. Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett 2011;585(2):269-74
   Google Scholar
• Powell DJ, Hajduch E, Kular G, et al. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol 2003;23(21):7794-808
   PubMed Web of Science ®Google Scholar
• Hajduch E, Turban S, Le Liepvre X, et al. Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide. Biochem J 2008;410(2):369-79
   Google Scholar
• Farese RV, Lee MC, Sajan MP. Atypical PKC: a target for treating insulin-resistant disorders of obesity, the metabolic syndrome and type 2 diabetes mellitus. Expert Opin Ther Targets 2014;18(10):1163-75
   PubMed Web of Science ®Google Scholar
• Fox TE, Houck KL, O’Neill SM, et al. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J Biol Chem 2007;282(17):12450-7
   Google Scholar
• Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387(6633):569-72
   PubMed Web of Science ®Google Scholar
• Oka N, Yamamoto M, Schwencke C, et al. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem 1997;272(52):33416-21
   PubMed Web of Science ®Google Scholar
• Blouin CM, Prado C, Takane KK, et al. Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling. Diabetes 2010;59(3):600-10
   Google Scholar
• Yamaguchi M, Miyashita Y, Kumagai Y, et al. Change in liver and plasma ceramides during D-galactosamine-induced acute hepatic injury by LC-MS/MS. Bioorg Med Chem Lett 2004;14(15):4061-4
   Google Scholar
• Monetti M, Levin MC, Watt MJ, et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 2007;6(1):69-78
   PubMed Web of Science ®Google Scholar
• Holland WL, Bikman BT, Wang LP, et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011;121(5):1858-70
   PubMed Web of Science ®Google Scholar
• Yang G, Badeanlou L, Bielawski J, et al. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2009;297(1):E211-24
   PubMed Web of Science ®Google Scholar
• Kurek K, Piotrowska DM, Wiesiolek-Kurek P, et al. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Liver Int 2013;34(7):1074-83
   Google Scholar
• Turpin SM, Nicholls HT, Willmes DM, et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 2014;20(4):678-86
   PubMed Web of Science ®Google Scholar
• Raichur S, Wang ST, Chan PW, et al. CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab 2014;20(4):687-95
   PubMed Web of Science ®Google Scholar
• Merrill AHJr, Lingrell S, Wang E, et al. Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion. J Biol Chem 1995;270(23):13834-41
   Google Scholar
• Boon J, Hoy AJ, Stark R, et al. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 2013;62(2):401-10
   PubMed Web of Science ®Google Scholar
• Sajan MP, Acevedo-Duncan ME, Standaert ML, et al. Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity. Diabetes 2014;63(8):2690-701
   PubMed Web of Science ®Google Scholar
• Friedman RM, Metz DH, Esteban RM, et al. Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts. J Virol 1972;10(6):1184-98
   Google Scholar
• Dabo S, Meurs EF. dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection. Viruses 2012;4(11):2598-635
   PubMed Web of Science ®Google Scholar
• Carvalho BM, Oliveira AG, Ueno M, et al. Modulation of double-stranded RNA-activated protein kinase in insulin sensitive tissues of obese humans. Obesity (Silver Spring) 2013;21(12):2452-7
   Google Scholar
• Yang X, Nath A, Opperman MJ, et al. The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells. Mol Biol Cell 2010;21(19):3449-58
   Google Scholar
• Nakamura T, Arduini A, Baccaro B, et al. Small-molecule inhibitors of PKR improve glucose homeostasis in obese diabetic mice. Diabetes 2014;63(2):526-34
   Google Scholar
• Kolak M, Westerbacka J, Velagapudi VR, et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007;56(8):1960-8
   Google Scholar
• Shah C, Yang G, Lee I, et al. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 2008;283(20):13538-48
   PubMed Web of Science ®Google Scholar
• Long SD, Pekala PH. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem J 1996;319(Pt 1):179-84
   Google Scholar
• Barbarroja N, Rodriguez-Cuenca S, Nygren H, et al. Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function. Diabetes 2014. [Epub ahead of print]
   Google Scholar
• Veluthakal R, Palanivel R, Zhao Y, et al. Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying ceramide-mediated metabolic dysfunction of the beta cell. Apoptosis 2005;10(4):841-50
   Google Scholar
• Veret J, Coant N, Berdyshev EV, et al. Ceramide synthase 4 and de novo production of ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 beta-cells. Biochem J 2011;438(1):177-89
   Google Scholar
• Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001;15(2):312-21
   PubMed Web of Science ®Google Scholar
• Kogot-Levin A, Saada A. Ceramide and the mitochondrial respiratory chain. Biochimie 2014;100:88-94
   Google Scholar
• Lang F, Ullrich S, Gulbins E. Ceramide formation as a target in beta-cell survival and function. Expert Opin Ther Targets 2011;15(9):1061-71
   Web of Science ®Google Scholar
• Laybutt DR, Preston AM, Akerfeldt MC, et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007;50(4):752-63
   PubMed Web of Science ®Google Scholar
• Boslem E, MacIntosh G, Preston AM, et al. A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem J 2011;435(1):267-76
   Google Scholar
• Park JW, Park WJ, Kuperman Y, et al. Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes. Hepatology 2013;57(2):525-32
   PubMed Web of Science ®Google Scholar
• Gjoni E, Brioschi L, Cinque A, et al. Glucolipotoxicity Impairs Ceramide Flow from the Endoplasmic Reticulum to the Golgi Apparatus in INS-1 beta-Cells. PLoS One 2014;9(10):e110875
   Google Scholar
• Riboni L, Giussani P, Viani P. Sphingolipid transport. Adv Exp Med Biol 2010;688:24-45
   PubMed Web of Science ®Google Scholar
• Kelpe CL, Moore PC, Parazzoli SD, et al. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem 2003;278(32):30015-21
   Google Scholar
• Hagman DK, Hays LB, Parazzoli SD, et al. Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J Biol Chem 2005;280(37):32413-18
   PubMed Web of Science ®Google Scholar
• Mathias S, Pena LA, Kolesnick RN. Signal transduction of stress via ceramide. Biochem J 1998;335(Pt 3):465-80
   PubMedGoogle Scholar
• Kaneto H, Xu G, Fujii N, et al. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 2002;277(33):30010-18
   PubMed Web of Science ®Google Scholar
• Guo J, Qian Y, Xi X, et al. Blockage of ceramide metabolism exacerbates palmitate inhibition of pro-insulin gene expression in pancreatic beta-cells. Mol Cell Biochem 2010;338(1-2):283-90
   Google Scholar
• Guo J, Zhu JX, Deng XH, et al. Palmitate-induced inhibition of insulin gene expression in rat islet beta-cells involves the ceramide transport protein. Cell Physiol Biochem 2010;26(4-5):717-28
   Google Scholar
• Yano M, Watanabe K, Yamamoto T, et al. Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice. J Biol Chem 2011;286(5):3992-4002
   Google Scholar
• Le Stunff H, Coant N, Migrenne S, et al. Targeting lipid sensing in the central nervous system: new therapy against the development of obesity and type 2 diabetes. Expert Opin Ther Targets 2013;17(5):545-55
   PubMed Web of Science ®Google Scholar
• Martinez de Morentin PB, Varela L, Ferno J, et al. Hypothalamic lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 2009;1801(3):350-61
   Google Scholar
• Contreras C, Gonzalez-Garcia I, Martinez-Sanchez N, et al. Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance. Cell Rep 2014;9(1):366-77
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang G, Zhang H, et al. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008;135(1):61-73
   PubMed Web of Science ®Google Scholar
• Le Stunff H, Milstien S, Spiegel S. Generation and metabolism of bioactive sphingosine-1-phosphate. J Cell Biochem 2004;92(5):882-99
   PubMed Web of Science ®Google Scholar
• Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003;4(5):397-407
   PubMed Web of Science ®Google Scholar
• Aarthi JJ, Darendeliler MA, Pushparaj PN. Dissecting the role of the S1P/S1PR axis in health and disease. J Dent Res 2011;90(7):841-54
   PubMed Web of Science ®Google Scholar
• Mitra P, Oskeritzian CA, Payne SG, et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA 2006;103(44):16394-9
   Google Scholar
• Okajima F. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta 2002;1582(1-3):132-7
   PubMed Web of Science ®Google Scholar
• Rapizzi E, Taddei ML, Fiaschi T, et al. Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. Cell Mol Life Sci 2009;66(19):3207-18
   PubMed Web of Science ®Google Scholar
• Bruce CR, Risis S, Babb JR, et al. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice. Endocrinology 2013;154(1):65-76
   Google Scholar
• Bruce CR, Risis S, Babb JR, et al. Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice. Diabetes 2012;61(12):3148-55
   Google Scholar
• Ma MM, Chen JL, Wang GG, et al. Sphingosine kinase 1 participates in insulin signalling and regulates glucose metabolism and homeostasis in KK/Ay diabetic mice. Diabetologia 2007;50(4):891-900
   Google Scholar
• Kendall MR, Hupfeld CJ. FTY720, a sphingosine-1-phosphate receptor modulator, reverses high-fat diet-induced weight gain, insulin resistance and adipose tissue inflammation in C57BL/6 mice. Diabetes Obes Metab 2008;10(9):802-5
   Google Scholar
• Qi Y, Chen J, Lay A, et al. Loss of sphingosine kinase 1 predisposes to the onset of diabetes via promoting pancreatic beta-cell death in diet-induced obese mice. FASEB J 2013;27(10):4294-304
   PubMed Web of Science ®Google Scholar
• Ross JS, Hu W, Rosen B, et al. Sphingosine kinase 1 is regulated by peroxisome proliferator-activated receptor alpha in response to free fatty acids and is essential for skeletal muscle interleukin-6 production and signaling in diet-induced obesity. J Biol Chem 2013;288(31):22193-206
   Google Scholar
• Schuppel M, Kurschner U, Kleuser U, et al. Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. J Invest Dermatol 2008;128(7):1747-56
   Google Scholar
• Osawa Y, Seki E, Kodama Y, et al. Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression. FASEB J 2011;25(4):1133-44
   Google Scholar
• Osawa Y, Uchinami H, Bielawski J, et al. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. J Biol Chem 2005;280(30):27879-87
   PubMed Web of Science ®Google Scholar
• Fayyaz S, Henkel J, Japtok L, et al. Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype. Diabetologia 2014;57(2):373-82
   PubMed Web of Science ®Google Scholar
• Laychock SG, Sessanna SM, Lin MH, et al. Sphingosine 1-phosphate affects cytokine-induced apoptosis in rat pancreatic islet beta-cells. Endocrinology 2006;147(10):4705-12
   Google Scholar
• Veret J, Coant N, Gorshkova IA, et al. Role of palmitate-induced sphingoid base-1-phosphate biosynthesis in INS-1 beta-cell survival. Biochim Biophys Acta 2013;1831(2):251-62
   Google Scholar
• Shimizu H, Okajima F, Kimura T, et al. Sphingosine 1-phosphate stimulates insulin secretion in HIT-T 15 cells and mouse islets. Endocr J 2000;47(3):261-9
   Google Scholar
• Cantrell Stanford J, Morris AJ, Sunkara M, et al. Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells. J Biol Chem 2012;287(16):13457-64
   PubMed Web of Science ®Google Scholar
• Samad F, Hester KD, Yang G, et al. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 2006;55(9):2579-87
   PubMed Web of Science ®Google Scholar
• Imasawa T, Koike K, Ishii I, et al. Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells. Biochem Biophys Res Commun 2010;392(2):207-11
   Google Scholar
• Levy M, Futerman AH. Mammalian ceramide synthases. IUBMB Life 2010;62(5):347-56
   PubMed Web of Science ®Google Scholar
• Wang J, Badeanlou L, Bielawski J, et al. Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance. Am J Physiol Endocrinol Metab 2014;306(7):E756-68
   PubMed Web of Science ®Google Scholar
• Sassa T, Ohno Y, Suzuki S, et al. Impaired epidermal permeability barrier in mice lacking elovl1, the gene responsible for very-long-chain fatty acid production. Mol Cell Biol 2013;33(14):2787-96
   PubMed Web of Science ®Google Scholar
• Jennemann R, Rabionet M, Gorgas K, et al. Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum Mol Genet 2011;21(3):586-608
   Google Scholar
• Schulze H, Michel C, van Echten-Deckert G. Dihydroceramide desaturase. Methods Enzymol 2000;311:22-30
   Google Scholar
• Holland WL, Brozinick JT, Wang LP, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007;5(3):167-79
   PubMed Web of Science ®Google Scholar
• Schiffmann S, Hartmann D, Fuchs S, et al. Inhibitors of specific ceramide synthases. Biochimie 2012;94(2):558-65
   Google Scholar
• Holland WL, Miller RA, Wang ZV, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011;17(1):55-63
   PubMed Web of Science ®Google Scholar